Harnessing the beneficial properties of adipogenic microbes for improving human health

Obesity Reviews

Volumn 14, Issue 9, 2013, Pages 721-735

  Dhurandhar, N V ^a   Geurts, L ^b   Atkinson, R L ^c   Casteilla, L ^d   Clement, K ^e   Gerard, P ^f   Vijay Kumar, M ^g   Nam, J H ^h   Nieuwdorp, M ⁱ   Trovato, G ^j   Sorensen T I A ^k,l   Vidal Puig, A ^m   Cani, P D ^b  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c Obetech Obesity Research Center   (United States)

^d CNRS   (France)

^e CENTRE DE RECHERCHE DES CORDELIERS   (France)

^f UMR1319 MICALIS   (France)

^g PENNSYLVANIA STATE UNIVERSITY   (United States)

^h The Catholic University of Korea   (South Korea)

ⁱ UNIVERSITY OF AMSTERDAM   (Netherlands)

^j UNIVERSITY OF CATANIA   (Italy)

^k UNIVERSITY OF COPENHAGEN   (Denmark)

^l The Capital Region   (Denmark)

^m UNIVERSITY OF CAMBRIDGE   (United Kingdom)

more..

Author keywords

Ad36; Diabetes; Microbiota; Obesity.

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; GLUCOSE; LIPID;

ADENOVIRUS INFECTION; ADIPOCYTE; ADIPOGENESIS; ADIPOGENIC MICROBES; ADIPOSE TISSUE; ARTICLE; AVIADENOVIRUS; BACTEROIDES; COMORBIDITY; ENERGY BALANCE; ENERGY EXPENDITURE; FAECALIBACTERIUM PRAUSNITZII; FOOD INTAKE; GAMMAPROTEOBACTERIA; GLUCOSE HOMEOSTASIS; HUMAN; HUMAN ADENOVIRUS 5; INSULIN SENSITIVITY; INTESTINE FLORA; LIPID STORAGE; LIPOGENESIS; MACROPHAGE; NONHUMAN; OBESITY; PHYSICAL ACTIVITY; PREVOTELLA; PROADIPOCYTE; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; VIRUS INFECTION; WEIGHT GAIN; WEIGHT REDUCTION; BLOOD; GASTROINTESTINAL TRACT; HOMEOSTASIS; METABOLIC DISORDER; METABOLISM; MICROBIOLOGY; MICROFLORA;

ADIPOGENESIS; ADIPOSE TISSUE; COMORBIDITY; GASTROINTESTINAL TRACT; GLUCOSE; HOMEOSTASIS; HUMANS; LIPIDS; METABOLIC DISEASES; MICROBIOTA; OBESITY; WEIGHT LOSS;

EID: 84881616017     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/obr.12045     Document Type: Article

References (125)

1. Sorensen TI. Conference on 'Multidisciplinary approaches to nutritional problems'. Symposium on 'Diabetes and health'. Challenges in the study of causation of obesity. Proc Nutr Soc 2009; 68: 43-54.
2. Sorensen TI. Is obesity a healthy active response to an expected future lack of energy rather than a passive storage of surplus energy? Obes Facts 2012; 5: 431-435.
3. Li X, Cope MB, Johnson MS, Smith DL Jr, Nagy TR. Mild calorie restriction induces fat accumulation in female C57BL/6J mice. Obesity (Silver Spring) 2010; 18: 456-462.
4. Summerbell CD, Douthwaite W, Whittaker V etal. The association between diet and physical activity and subsequent excess weight gain and obesity assessed at 5 years of age or older: a systematic review of the epidemiological evidence. Int J Obes (Lond) 2009; 33 (Suppl. 3): S1-92.
5. Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med 2011; 364: 2392-2404.
6. Sorensen TI. Obesity defined as excess storage of inert triglycerides - do we need a paradigm shift? Obes Facts 2011; 4: 91-94.
7. Dhurandhar NV. When commonsense does not make sense. Int J Obes (Lond) 2012; 36: 1332-1333.
8. Harrington M, Gibson S, Cottrell RC. A review and meta-analysis of the effect of weight loss on all-cause mortality risk. Nutr Res Rev 2009; 22: 93-108.
9. Berentzen T, Sorensen TI. Effects of intended weight loss on morbidity and mortality: possible explanations of controversial results. Nutr Rev 2006; 64: 502-507.
10. Dhurandhar NV. A framework for identification of infections that contribute to human obesity. Lancet Infect Dis 2011; 11: 963-969.
11. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027-1031.
12. Krishnapuram R, Dhurandhar EJ, Dubuisson O etal. Template to improve glycemic control without reducing adiposity or dietary fat. Am J Physiol Endocrinol Metab 2011; 300: E779-E789.
13. Trovato GM, Martines GF, Garozzo A etal. Ad36 adipogenic adenovirus in human non-alcoholic fatty liver disease. Liver Int 2010; 30: 184-190.
14. Trovato GM, Martines GF, Trovato FM etal. Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistance. Dig Dis Sci 2012; 57: 535-544.
15. Backhed F, Ding H, Wang T etal. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 2004; 101: 15718-15723.
16. Pasarica M, Mashtalir N, McAllister EJ etal. Adipogenic human adenovirus Ad-36 induces commitment, differentiation, and lipid accumulation in human adipose-derived stem cells. Stem Cells 2008; 26: 969-978.
17. Pasarica M, Loiler S, Dhurandhar NV. Acute effect of infection by adipogenic human adenovirus Ad36. Arch Virol 2008; 153: 2097-2102.
18. Cani PD, Neyrinck AM, Fava F etal. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007; 50: 2374-2383.
19. Khan T, Muise ES, Iyengar P etal. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol Cell Biol 2009; 29: 1575-1591.
20. Kim JY, van de Wall E, Laplante M etal. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 2007; 117: 2621-2637.
21. Sewter C, Vidal-Puig A. PPARgamma and the thiazolidinediones: molecular basis for a treatment of 'Syndrome X'? Diabetes Obes Metab 2002; 4: 239-248.
22. Delzenne NM, Neyrinck AM, Backhed F, Cani PD. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol 2011; 7: 639-646.
23. Dubuisson O, Dhurandhar EJ, Krishnapuram R etal. PPARgamma-independent increase in glucose uptake and adiponectin abundance in fat cells. Endocrinology 2011; 152: 3648-3660.
24. Dhurandhar EJ, Dubuisson O, Mashtalir N, Krishnapuram R, Hegde V, Dhurandhar NV. E4orf1: a novel ligand that improves glucose disposal in cell culture. Plos ONE 2011; 6: e23394.
25. Cadwell K, Patel KK, Maloney NS etal. Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell 2010; 141: 1135-1145.
26. Kane M, Case LK, Kopaskie K etal. Successful transmission of a retrovirus depends on the commensal microbiota. Science 2011; 334: 245-249.
27. Virtue S, Vidal-Puig A. It's not how fat you are, it's what you do with it that counts. Plos Biol 2008; 6: e237.
28. Virtue S, Vidal-Puig A. Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome - an allostatic perspective. Biochim Biophys Acta 2010; 1801: 338-349.
29. Roth J, Szulc AL, Danoff A. Energy, evolution, and human diseases: an overview. Am J Clin Nutr 2011; 93: 875S-8783.
30. Procaccini C, Jirillo E, Matarese G. Leptin as an immunomodulator. Mol Aspects Med 2012; 33: 35-45.
31. Pond CM. Adipose tissue and the immune system. Prostaglandins Leukot Essent Fatty Acids 2005; 73: 17-30.
32. Bjorntorp P, Karlsson M, Pettersson P, Sypniewska G. Differentiation and function of rat adipocyte precursor cells in primary culture. J Lipid Res 1980; 21: 714-723.
33. Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res 2007; 100: 1249-1260.
34. Casteilla L, Planat-Benard V, Laharrague P, Cousin B. Adipose-derived stromal cells: their identity and uses in clinical trials, an update. World J Stem Cells 2011; 3: 25-33.
35. Cousin B, Munoz O, Andre M etal. A role for preadipocytes as macrophage-like cells. FASEB J 1999; 13: 305-312.
36. Charriere GM, Cousin B, Arnaud E etal. Macrophage characteristics of stem cells revealed by transcriptome profiling. Exp Cell Res 2006; 312: 3205-3214.
37. Charriere G, Cousin B, Arnaud E etal. Preadipocyte conversion to macrophage. Evidence of plasticity. J Biol Chem 2003; 278: 9850-9855.
38. Hotamisligil GS, Erbay E. Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol 2008; 8: 923-934.
39. Cousin B, Andre M, Casteilla L, Penicaud L. Altered macrophage-like functions of preadipocytes in inflammation and genetic obesity. J Cell Physiol 2001; 186: 380-386.
40. Puissant B, Barreau C, Bourin P etal. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 2005; 129: 118-129.
41. Mei SH, Haitsma JJ, Dos Santos CC etal. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am J Respir Crit Care Med 2010; 182: 1047-1057.
42. Krasnodembskaya A, Samarani G, Song Y etal. Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes. Am J Physiol Lung Cell Mol Physiol 2012; 302: L1003-L1013.
43. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW, Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808.
44. De Toni F, Poglio S, Youcef AB etal. Human adipose-derived stromal cells efficiently support hematopoiesis in vitro and in vivo: a key step for therapeutic studies. Stem Cells Dev 2011; 20: 2127-2138.
45. Poglio S, De Toni F, Lewandowski D etal. In situ production of innate immune cells in murine white adipose tissue. Blood 2012; 120: 4952-4962.
46. Lyons MJ, Faust IM, Hemmes RB, Buskirk DR, Hirsch J, Zabriskie JB. A virally induced obesity syndrome in mice. Science 1982; 216: 82-85.
47. Carter JK, Ow CL, Smith RE. Rous-associated virus type 7 induces a syndrome in chickens characterized by stunting and obesity. Infect Immun 1983; 39: 410-422.
48. Gosztonyi G, Ludwig H. Borna disease - neuropathology and pathogenesis. Curr Top Microbiol Immunol 1995; 190: 39-73.
49. Carp RI, Meeker H, Sersen E, Kozlowski P. Analysis of the incubation periods, induction of obesity and histopathological changes in senescence-prone and senescence-resistant mice infected with various scrapie strains. J Gen Virol 1998; 79 (Pt 11): 2863-2869.
50. Dhurandhar NV, Kulkarni PR, Ajinkya SM, Sherikar AA, Atkinson RL. Association of adenovirus infection with human obesity. Obes Res 1997; 5: 464-469.
51. Wigand R, Gelderblom H, Wadell G. New human adenovirus (candidate adenovirus 36), a novel member of subgroup D. Arch Virol 1980; 64: 225-233.
52. Hierholzer JC, Wigand R, Anderson LJ, Adrian T, Gold JW. Adenoviruses from patients with AIDS: a plethora of serotypes and a description of five new serotypes of subgenus D (types 43-47). J Infect Dis 1988; 158: 804-813.
53. Dhurandhar NV, Israel BA, Kolesar JM, Mayhew GF, Cook ME, Atkinson RL. Increased adiposity in animals due to a human virus. Int J Obes Relat Metab Disord 2000; 24: 989-996.
54. Dhurandhar NV, Israel BA, Kolesar JM, Mayhew G, Cook ME, Atkinson RL. Transmissibility of adenovirus-induced adiposity in a chicken model. Int J Obes Relat Metab Disord 2001; 25: 990-996.
55. Kolesar JM, Miller JA, Dhurandhar NV, Atkinson RL. Direct quantification of AD-36 adenovirus DNA by capillary electrophoresis with laser-induced fluorescence. J Chromatogr B Biomed Sci Appl 2000; 744: 1-8.
56. Dhurandhar NV, Whigham LD, Abbott DH etal. Human adenovirus Ad-36 promotes weight gain in male rhesus and marmoset monkeys. J Nutr 2002; 132: 3155-3160.
57. Whigham LD, Israel BA, Atkinson RL. Adipogenic potential of multiple human adenoviruses in vivo and in vitro in animals. Am J Physiol Regul Integr Comp Physiol 2006; 290: R190-R194.
58. Pasarica M, Shin AC, Yu M etal. Human adenovirus 36 induces adiposity, increases insulin sensitivity, and alters hypothalamic monoamines in rats. Obesity (Silver Spring) 2006; 14: 1905-1913.
59. Krishnapuram R, Kirk-Ballard H, Zuberi A, Dhurandhar NV. Infectivity period of mice inoculated with human adenoviruses. Lab Anim 2011; 45: 103-108.
60. Na HN, Nam JH. Adenovirus 36 as an obesity agent maintains the obesity state by increasing MCP-1 and inducing inflammation. J Infect Dis 2012; 205: 914-922.
61. Vangipuram SD, Sheele J, Atkinson RL, Holland TC, Dhurandhar NV. A human adenovirus enhances preadipocyte differentiation. Obes Res 2004; 12: 770-777.
62. Rathod M, Vangipuram SD, Krishnan B, Heydari AR, Holland TC, Dhurandhar NV. Viral mRNA expression but not DNA replication is required for lipogenic effect of human adenovirus Ad-36 in preadipocytes. Int J Obes (Lond) 2007; 31: 78-86.
63. Rogers PM, Fusinski KA, Rathod MA etal. Human adenovirus Ad-36 induces adipogenesis via its E4 orf-1 gene. Int J Obes (Lond) 2008; 32: 397-406.
64. Rogers PM, Mashtalir N, Rathod MA etal. Metabolically favorable remodeling of human adipose tissue by human adenovirus type 36. Diabetes 2008; 57: 2321-2331.
65. Wang ZQ, Cefalu WT, Zhang XH etal. Human adenovirus type 36 enhances glucose uptake in diabetic and nondiabetic human skeletal muscle cells independent of insulin signaling. Diabetes 2008; 57: 1805-1813.
66. Rathod MA, Rogers PM, Vangipuram SD, McAllister EJ, Dhurandhar NV. Adipogenic cascade can be induced without adipogenic media by a human adenovirus. Obesity (Silver Spring) 2009; 17: 657-664.
67. Wang ZQ, Yu Y, Zhang XH, Floyd EZ, Cefalu WT. Human adenovirus 36 decreases fatty acid oxidation and increases de novo lipogenesis in primary cultured human skeletal muscle cells by promoting Cidec/FSP27 expression. Int J Obes (Lond) 2010; 34: 1355-1364.
68. Na HN, Kim H, Nam JH. Novel genes and cellular pathways related to infection with adenovirus-36 as an obesity agent in human mesenchymal stem cells. Int J Obes (Lond) 2012; 36: 195-200.
69. Krishnapuram R, Kirk-Ballard H, Dhurandhar EJ etal. Insulin receptor-independent upregulation of cellular glucose uptake. Int J Obes (Lond) 2013; 37: 146-153.
70. Atkinson RL, Dhurandhar NV, Allison DB etal. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int J Obes (Lond) 2005; 29: 281-286.
71. Atkinson RL, Lee I, Shin HJ, He J. Human adenovirus-36 antibody status is associated with obesity in children. Int J Pediatr Obes 2010; 5: 157-160.
72. Isbell JM, Tamboli RA, Hansen EN etal. The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery. Diabetes Care 2010; 33: 1438-1442.
73. Gabbert C, Donohue M, Arnold J, Schwimmer JB. Adenovirus 36 and obesity in children and adolescents. Pediatrics 2010; 126: 721-726.
74. Almgren M, Atkinson R, He J etal. Adenovirus-36 is associated with obesity in children and adults in sweden as determined by rapid ELISA. Plos ONE 2012; 7: e41652.
75. Tosh AK, Broy-Aschenbrenner A, El Khatib J, Ge B. Adenovirus-36 antibody status & BMI comparison among obese Missouri adolescents. Mo Med 2012; 109: 402-403.
76. Trovato GM, Castro A, Tonzuso A etal. Human obesity relationship with Ad36 adenovirus and insulin resistance. Int J Obes (Lond) 2009; 33: 1402-1409.
77. Salehian B, Forman SJ, Kandeel FR, Bruner DE, He J, Atkinson RL. Adenovirus 36 DNA in adipose tissue of patient with unusual visceral obesity. Emerg Infect Dis 2010; 16: 850-852.
78. Broderick MP, Hansen CJ, Irvine M etal. Adenovirus 36 seropositivity is strongly associated with race and gender, but not obesity, among US military personnel. Int J Obes (Lond) 2010; 34: 302-308.
79. Ronnblom A, Hellstrom PM, Holst JJ, Theodorsson E, Danielsson A. Gastric myoelectrical activity and gut hormone secretion in myotonic dystrophy. Eur J Gastroenterol Hepatol 2001; 13: 825-831.
80. Rubicz R, Leach CT, Kraig E etal. Seroprevalence of 13 common pathogens in a rapidly growing U.S. minority population: Mexican Americans from San Antonio, TX. BMC Res Notes 2011; 4: 433.
81. Na HN, Hong YM, Kim J, Kim HK, Jo I, Nam JH. Association between human adenovirus-36 and lipid disorders in Korean schoolchildren. Int J Obes (Lond) 2010; 34: 89-93.
82. Lin WY, Dubuisson O, Rubicz R etal. Long-term changes in adiposity and glycemic control are associated with past adenovirus infection. Diabetes Care 2013; 36: 701-707.
83. Trovato GM, Martines GF, Pirri C etal. Obesity-independent association of human adenovirus Ad37 seropositivity with nonalcoholic fatty liver disease. J Clin Gastroenterol 2012; 46: e46-e54.
84. Trovato GM. Behavior, nutrition and lifestyle in a comprehensive health and disease paradigm: skills and knowledge for a predictive, preventive and personalized medicine. EPMA J 2012; 3: 8.
85. Lin W, Dubuisson O, Rubicz R etal. Long term changes in adiposity and glycemic control are associated with past adenovirus infection. Diabetes Care 2013; 36: 701-707.
86. Dhurandhar NV. Insulin sparing action of Adenovirus 36 and its E4orf1 protein. J Diabetes Complications 2013; 27: 191-199.
87. Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest 2011; 121: 2111-2117.
88. Gao ZG, Ye JP. Why do anti-inflammatory therapies fail to improve insulin sensitivity? Acta Pharmacol Sin 2012; 33: 182-188.
89. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004; 350: 664-671.
90. Rabot S, Membrez M, Bruneau A etal. Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism. FASEB J 2010; 24: 4948-4959.
91. Le Roy T, Llopis M, Lepage P etal. Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut 2012; PMID: 23197411.
92. Furet JP, Kong LC, Tap J etal. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 2010; 59: 3049-3057.
93. Graessler J, Qin Y, Zhong H etal. Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters. Pharmacogenomics J 2012. doi: 10.1038/tpj.2012.43.
94. Zhang H, DiBaise JK, Zuccolo A etal. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A 2009; 106: 2365-2370.
95. Li JV, Ashrafian H, Bueter M etal. Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut 2011; 60: 1214-1223.
96. Cani PD, Amar J, Iglesias MA etal. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56: 1761-1772.
97. Cani PD, Bibiloni R, Knauf C etal. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008; 57: 1470-1481.
98. Cani PD, Possemiers S, Van de Wiele T etal. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009; 58: 1091-1103.
99. Cani PD, Dewever C, Delzenne NM. Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats. Br J Nutr 2004; 92: 521-526.
100. Cani PD, Neyrinck AM, Maton N, Delzenne NM. Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1. Obes Res 2005; 13: 1000-1007.
101. Delzenne NM, Cani PD, Daubioul C, Neyrinck AM. Impact of inulin and oligofructose on gastrointestinal peptides. Br J Nutr 2005; 93 (Suppl. 1): S157-161.
102. Everard A, Lazarevic V, Derrien M etal. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 2011; 60: 2775-2786.
103. Cani PD, Hoste S, Guiot Y, Delzenne NM. Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats. Br J Nutr 2007; 98: 32-37.
104. Roberfroid M, Gibson GR, Hoyles L etal. Prebiotic effects: metabolic and health benefits. Br J Nutr 2010; 104: S1-S63.
105. Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 1987; 28: 1221-1227.
106. Dewulf EM, Cani PD, Neyrinck AM etal. Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARgamma-related adipogenesis in the white adipose tissue of high-fat diet-fed mice. J Nutr Biochem 2011; 22: 712-722.
107. Muccioli GG, Naslain D, Backhed F etal. The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol 2010; 6: 392.
108. Tolhurst G, Heffron H, Lam YS etal. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 2012; 61: 364-371.
109. Reimann F, Habib AM, Tolhurst G, Parker HE, Rogers GJ, Gribble FM. Glucose sensing in L cells: a primary cell study. Cell Metab 2008; 8: 532-539.
110. Cani PD, Osto M, Geurts L, Everard A. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 2012; 3: 279-288.
111. Akira S. TLR signaling. Curr Top Microbiol Immunol 2006; 311: 1-16.
112. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 2004; 430: 257-263.
113. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118: 229-241.
114. Vijay-Kumar M, Sanders CJ, Taylor RT etal. Deletion of TLR5 results in spontaneous colitis in mice. J Clin Invest 2007; 117: 3909-3921.
115. Vijay-Kumar M, Aitken JD, Carvalho FA etal. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 2010; 328: 228-231.
116. de Vos WM, de Vos EA. Role of the intestinal microbiome in health and disease: from correlation to causation. Nutr Rev 2012; 70 (Suppl. 1): S45-S56.
117. Vrieze A, Van Nood E, Holleman F etal. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012; 143: 913-916.
118. Sørensen TIA, Rokholm B, Ajslev TA. The history of the obesity epidemic in denmark [Book chapter 9]. In: Offer A, Pechey R, Ulijaszek S (eds). Insecurity, Inequality, and Obesity in Affluent Societies. Proceedings of the British Academy. The British Academy: London, 2012, pp. 161-178.
119. Tan CY, Vidal-Puig A. Adipose tissue expandability: the metabolic problems of obesity may arise from the inability to become more obese. Biochem Soc Trans 2008; 36: 935-940.
120. Sorensen TI, Virtue S, Vidal-Puig A. Obesity as a clinical and public health problem: is there a need for a new definition based on lipotoxicity effects? Biochim Biophys Acta 2010; 1801: 400-404.
121. Dhurandhar NV. Is obesity caused by an adenovirus? Expert Rev Anti Infect Ther 2012; 10: 521-524.
122. Na HN, Hong YM, Kim J, Kim HK, Jo I, Nam JH. Association between human adenovirus-36 and lipid disorders in Korean schoolchildren. Int J Obes (Lond) 2009; 34: 89-93.
123. Na HN, Kim J, Lee HS etal. Association of human adenovirus-36 in overweight Korean adults. Int J Obes (Lond) 2012; 36: 281-285.
124. Dhurandhar EJ, Krishnapuram R, Hegde V etal. E4orf1 improves lipid and glucose metabolism in hepatocytes: a template to improve steatosis & hyperglycemia. PLoS ONE 2012; 7: e47813.
125. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science 2005; 307: 1915-1920.